pubmed-article:17722112 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:17722112 | lifeskim:mentions | umls-concept:C0021344 | lld:lifeskim |
pubmed-article:17722112 | lifeskim:mentions | umls-concept:C0302592 | lld:lifeskim |
pubmed-article:17722112 | lifeskim:mentions | umls-concept:C0012634 | lld:lifeskim |
pubmed-article:17722112 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
pubmed-article:17722112 | lifeskim:mentions | umls-concept:C0017431 | lld:lifeskim |
pubmed-article:17722112 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
pubmed-article:17722112 | lifeskim:mentions | umls-concept:C1527148 | lld:lifeskim |
pubmed-article:17722112 | lifeskim:mentions | umls-concept:C0681842 | lld:lifeskim |
pubmed-article:17722112 | lifeskim:mentions | umls-concept:C2346689 | lld:lifeskim |
pubmed-article:17722112 | lifeskim:mentions | umls-concept:C1550025 | lld:lifeskim |
pubmed-article:17722112 | lifeskim:mentions | umls-concept:C1551358 | lld:lifeskim |
pubmed-article:17722112 | lifeskim:mentions | umls-concept:C1709634 | lld:lifeskim |
pubmed-article:17722112 | pubmed:issue | 12 | lld:pubmed |
pubmed-article:17722112 | pubmed:dateCreated | 2007-10-31 | lld:pubmed |
pubmed-article:17722112 | pubmed:abstractText | Cervicovaginal human papillomavirus (HPV) viral load has been purported as a potential marker for the detection of high-grade cervical intraepithelial neoplasia or cancer (>/=CIN2). To examine disease association with type-specific viral load for the full-range of anogenital HPV infections, we conducted cross-sectional and prospective analyses of approximately 2,000 HPV-infected women from a 10,000-woman population-based study in Guanacaste, Costa Rica with 7 years of follow-up. Cervical specimens were tested for >40 HPV types using a MY09/MY11 L1 consensus primer PCR method with type-specific dot blot hybridization and PCR signal intensity as a measure of viral load. A positive association was observed between prevalent >/=CIN2 and high viral load compared to low viral load for women with baseline single HPV16 infections (OR = 19.2, 95% CI = 4.4-83.2) and single non-16 carcinogenic infections (OR = 9.2, 95% CI = 2.1-39.9). Inclusion of women with multiple HPV types did not substantially change these associations. In prospective follow-up, only women infected with HPV16 alone (OR = 27.2, 95% = 3.5-213.5) had a strong association between high viral load and incident >/=CIN2; non-16 carcinogenic high viral load was not associated with incident >/=CIN2 (OR = 0.7, 95% CI = 0.2-1.9). Single noncarcinogenic type viral load was not associated with increased risk of prevalent or incident >/=CIN2 (OR = 1.2 and 1.1, respectively). In conclusion, carcinogenic high viral load was associated with prevalent >/=CIN2; however HPV16 was uniquely associated with incident >/=CIN2. The extent to which these observations can be translated into clinical practice must be rigorously examined in the context of the method of viral load measurement and the type-specific differences observed for incident >/=CIN2. | lld:pubmed |
pubmed-article:17722112 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17722112 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17722112 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17722112 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17722112 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17722112 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17722112 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17722112 | pubmed:language | eng | lld:pubmed |
pubmed-article:17722112 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17722112 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:17722112 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17722112 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:17722112 | pubmed:month | Dec | lld:pubmed |
pubmed-article:17722112 | pubmed:issn | 1097-0215 | lld:pubmed |
pubmed-article:17722112 | pubmed:author | pubmed-author:BurkRobert... | lld:pubmed |
pubmed-article:17722112 | pubmed:author | pubmed-author:ShermanMark... | lld:pubmed |
pubmed-article:17722112 | pubmed:author | pubmed-author:SchiffmanMark... | lld:pubmed |
pubmed-article:17722112 | pubmed:author | pubmed-author:HerreroRoland... | lld:pubmed |
pubmed-article:17722112 | pubmed:author | pubmed-author:HildesheimAll... | lld:pubmed |
pubmed-article:17722112 | pubmed:author | pubmed-author:WacholderShol... | lld:pubmed |
pubmed-article:17722112 | pubmed:author | pubmed-author:MoralesJorgeJ | lld:pubmed |
pubmed-article:17722112 | pubmed:author | pubmed-author:AlfaroMarioM | lld:pubmed |
pubmed-article:17722112 | pubmed:author | pubmed-author:GravittPatti... | lld:pubmed |
pubmed-article:17722112 | pubmed:author | pubmed-author:RodriguezAna-... | lld:pubmed |
pubmed-article:17722112 | pubmed:author | pubmed-author:KovacicMelind... | lld:pubmed |
pubmed-article:17722112 | pubmed:author | pubmed-author:BrattiConcepc... | lld:pubmed |
pubmed-article:17722112 | pubmed:copyrightInfo | (c) 2007 Wiley-Liss, Inc. | lld:pubmed |
pubmed-article:17722112 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:17722112 | pubmed:day | 15 | lld:pubmed |
pubmed-article:17722112 | pubmed:volume | 121 | lld:pubmed |
pubmed-article:17722112 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:17722112 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:17722112 | pubmed:pagination | 2787-93 | lld:pubmed |
pubmed-article:17722112 | pubmed:meshHeading | pubmed-meshheading:17722112... | lld:pubmed |
pubmed-article:17722112 | pubmed:meshHeading | pubmed-meshheading:17722112... | lld:pubmed |
pubmed-article:17722112 | pubmed:meshHeading | pubmed-meshheading:17722112... | lld:pubmed |
pubmed-article:17722112 | pubmed:meshHeading | pubmed-meshheading:17722112... | lld:pubmed |
pubmed-article:17722112 | pubmed:meshHeading | pubmed-meshheading:17722112... | lld:pubmed |
pubmed-article:17722112 | pubmed:meshHeading | pubmed-meshheading:17722112... | lld:pubmed |
pubmed-article:17722112 | pubmed:meshHeading | pubmed-meshheading:17722112... | lld:pubmed |
pubmed-article:17722112 | pubmed:meshHeading | pubmed-meshheading:17722112... | lld:pubmed |
pubmed-article:17722112 | pubmed:meshHeading | pubmed-meshheading:17722112... | lld:pubmed |
pubmed-article:17722112 | pubmed:meshHeading | pubmed-meshheading:17722112... | lld:pubmed |
pubmed-article:17722112 | pubmed:meshHeading | pubmed-meshheading:17722112... | lld:pubmed |
pubmed-article:17722112 | pubmed:meshHeading | pubmed-meshheading:17722112... | lld:pubmed |
pubmed-article:17722112 | pubmed:meshHeading | pubmed-meshheading:17722112... | lld:pubmed |
pubmed-article:17722112 | pubmed:meshHeading | pubmed-meshheading:17722112... | lld:pubmed |
pubmed-article:17722112 | pubmed:meshHeading | pubmed-meshheading:17722112... | lld:pubmed |
pubmed-article:17722112 | pubmed:meshHeading | pubmed-meshheading:17722112... | lld:pubmed |
pubmed-article:17722112 | pubmed:meshHeading | pubmed-meshheading:17722112... | lld:pubmed |
pubmed-article:17722112 | pubmed:meshHeading | pubmed-meshheading:17722112... | lld:pubmed |
pubmed-article:17722112 | pubmed:meshHeading | pubmed-meshheading:17722112... | lld:pubmed |
pubmed-article:17722112 | pubmed:meshHeading | pubmed-meshheading:17722112... | lld:pubmed |
pubmed-article:17722112 | pubmed:meshHeading | pubmed-meshheading:17722112... | lld:pubmed |
pubmed-article:17722112 | pubmed:meshHeading | pubmed-meshheading:17722112... | lld:pubmed |
pubmed-article:17722112 | pubmed:meshHeading | pubmed-meshheading:17722112... | lld:pubmed |
pubmed-article:17722112 | pubmed:meshHeading | pubmed-meshheading:17722112... | lld:pubmed |
pubmed-article:17722112 | pubmed:year | 2007 | lld:pubmed |
pubmed-article:17722112 | pubmed:articleTitle | High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease. | lld:pubmed |
pubmed-article:17722112 | pubmed:affiliation | Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. pgravitt@jhsph.edu | lld:pubmed |
pubmed-article:17722112 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:17722112 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:17722112 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17722112 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17722112 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17722112 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17722112 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17722112 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17722112 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17722112 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17722112 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17722112 | lld:pubmed |